Eric Lee Nuermberger MD

Associate Professor of Medicine, Johns Hopkins University School of Medicine

1800 Orleans StreetBaltimore, MD 21287
Phone+1 410-955-5000
Fax+1 410-955-5001

Dr. Nuermberger is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Nuermberger's full profile Already have an account?

Education & Training

Johns Hopkins UniversityFellowship, Infectious Disease, 1999 - 2003
Johns Hopkins UniversityResidency, Internal Medicine, 1996 - 1999
Vanderbilt University School of MedicineClass of 1996

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

MD State Medical License 2000 - 2027
FL State Medical License 2015 - 2022
American Board of Internal Medicine Infectious Disease

Publications & Presentations

PubMed

Second-Generation Anti-Tubercular Squaramides Targeting Complex V of the Respiratory Chain ofDisplaying Enhanced Metabolic Stability.
Nada Mosallam, Paul M O'Neill, Monika Lisauskaitė, Christopher M Woodley, Alison Ardrey
Journal of Medicinal Chemistry. 2026-05-14
Immunotherapy targeting drug-tolerant Mycobacterium tuberculosis persisters accelerates tuberculosis cure in preclinical models.
Styliani Karanika, Tianyin Wang, Addis Yilma, Jennie Ruelas Castillo, James T Gordy
The Journal of Clinical Investigation. 2026-04-01
A Phase 2a Study of the Early Bactericidal Activity of Rifampicin in Combination With Meropenem Plus Amoxicillin/Clavulanate Among Adults With Rifampicin-Resistant Pul...
Veronique de Jager, Laurynas Mockeliunas, Huifang You, Ulrika S H Simonsson, Tarryn Collings
Clinical Infectious Diseases. 2025-12-24

Press Mentions

New Consortium Receives NIH Grant to Accelerate Development of Effective TB TreatmentsJuly 10th, 2024
Tip Sheet: Johns Hopkins Researchers Present at Annual CROI MeetingMarch 1st, 2018
Africa: Cure at Last for Multi-Drug-Resistant TBMarch 31st, 2017

Grant Support

Preclinical Design and Clinical Translation of TB Regimens (PReDicTR) ConsortiumUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2024–2029
Harnessing potent next-generation diarylquinolines for long-acting injectable formulations to prevent and treat tuberculosisJOHNS HOPKINS UNIVERSITY2021–2026
Harnessing potent next-generation diarylquinolines for long-acting injectable formulations to prevent and treat tuberculosisJOHNS HOPKINS UNIVERSITY2021–2026
Development of novel penems for drug-resistant tuberculosisJOHNS HOPKINS UNIVERSITY2018–2024
Advancing New Drug Regimens For Mdr/Xdr TBNational Institute Of Allergy And Infectious Diseases2010–2011